Acknowledgements
This study was supported in part by a Grant-in-Aid for Intractable Renal Diseases Research, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan.
aValues at the time of treatment initiation
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
In 2020, the Research for Intractable Renal Diseases of the Ministry of Health, Labour and Welfare of Japan established the Committee of Guideline for Rapidly Progressive Glomerulonephritis, which published (A digest from evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020) on the website (jin-shogai.jp/policy/index.html). This is the English version of that digest.
About this article
Cite this article
Usui, J., Kawashima, S., Sada, KE. et al. A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020. Clin Exp Nephrol 25, 1286–1291 (2021). https://doi.org/10.1007/s10157-021-02096-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-021-02096-7